Industry drives low uptake for EU-US parallel advice
This article was originally published in SRA
Executive Summary
The future of the parallel scientific advice pilot launched between the US and the European Union several years ago is “a never ending debate”, according to the European Medicines Agency’s senior medical officer. Inevitably, the status of the ailing programme was brought up during a Q&A session at the Drug Information Association’s 45th annual meeting held in San Diego, US, on 21-25 June.